Astellas Pharma Inc. (FRA:YPH)
Germany · Delayed Price · Currency is EUR 11.64
+0.32 (2.83%)
At close: Jan 30, 2026
Astellas Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 136,801 | 31,237 | 24,969 | 132,361 | 156,886 | 145,324 |
Depreciation & Amortization | 193,945 | 199,132 | 157,840 | 105,738 | 79,684 | 72,652 |
Loss (Gain) From Sale of Assets | 203,411 | 187,564 | 78,931 | 84,499 | 74,850 | 100,348 |
Other Operating Activities | -71,813 | -75,674 | -37,563 | -68,811 | -43,293 | -27,144 |
Change in Accounts Receivable | -121,462 | -104,735 | -55,948 | -4,849 | -8,001 | 22,161 |
Change in Inventory | -40,894 | -50,225 | -60,036 | -7,086 | 24,058 | -2,318 |
Change in Accounts Payable | 503 | -11,409 | 29,466 | -12,274 | -10,101 | -51,569 |
Change in Other Net Operating Assets | 99,209 | 18,622 | 34,816 | 98,189 | -16,639 | 47,389 |
Operating Cash Flow | 399,700 | 194,512 | 172,475 | 327,767 | 257,444 | 306,843 |
Operating Cash Flow Growth | 99.05% | 12.78% | -47.38% | 27.32% | -16.10% | 38.22% |
Capital Expenditures | -33,649 | -37,003 | -38,056 | -36,441 | -30,739 | -31,384 |
Sale of Property, Plant & Equipment | - | - | - | - | 441 | 6,831 |
Cash Acquisitions | - | - | -784,974 | - | -670 | -14,916 |
Sale (Purchase) of Intangibles | -31,215 | -19,168 | -33,438 | -51,888 | -21,428 | -46,057 |
Investment in Securities | 12,920 | 12,920 | - | 12,624 | - | - |
Other Investing Activities | -11,943 | -46,168 | 10,666 | -8,795 | -10,017 | 3,632 |
Investing Cash Flow | -63,887 | -89,419 | -845,802 | -84,500 | -62,413 | -81,894 |
Short-Term Debt Issued | - | - | 324,337 | - | - | - |
Long-Term Debt Issued | - | 200,000 | 472,275 | 50,000 | - | 80,000 |
Total Debt Issued | - | 200,000 | 796,612 | 50,000 | - | 80,000 |
Short-Term Debt Repaid | - | -236,449 | - | -15,000 | - | - |
Long-Term Debt Repaid | - | -52,073 | -25,379 | -50,000 | -60,000 | -206,000 |
Total Debt Repaid | -193,562 | -288,522 | -25,379 | -65,000 | -60,000 | -206,000 |
Net Debt Issued (Repaid) | -193,562 | -88,522 | 771,233 | -15,000 | -60,000 | -126,000 |
Repurchase of Common Stock | -730 | -6,960 | -10,735 | -60,556 | -50,717 | -9,163 |
Common Dividends Paid | -132,475 | -128,993 | -116,653 | -100,355 | -85,236 | -76,157 |
Other Financing Activities | -24,129 | -36,892 | -29,785 | -19,712 | -20,345 | -18,159 |
Financing Cash Flow | -350,896 | -261,367 | 614,060 | -195,623 | -216,298 | -229,479 |
Foreign Exchange Rate Adjustments | 9,145 | 8,960 | 18,113 | 13,210 | 11,125 | 12,267 |
Miscellaneous Cash Flow Adjustments | -1 | -1 | 1 | - | -1 | - |
Net Cash Flow | -5,939 | -147,315 | -41,153 | 60,854 | -10,143 | 7,737 |
Free Cash Flow | 366,051 | 157,509 | 134,419 | 291,326 | 226,705 | 275,459 |
Free Cash Flow Growth | 138.93% | 17.18% | -53.86% | 28.50% | -17.70% | 52.41% |
Free Cash Flow Margin | 18.24% | 8.24% | 8.38% | 19.18% | 17.49% | 22.05% |
Free Cash Flow Per Share | 203.69 | 87.64 | 74.69 | 159.63 | 122.50 | 148.24 |
Cash Income Tax Paid | 81,721 | 85,478 | 38,112 | 69,479 | 42,093 | 17,870 |
Levered Free Cash Flow | 298,722 | 125,260 | 134,671 | 202,242 | 174,913 | 155,051 |
Unlevered Free Cash Flow | 306,847 | 133,980 | 139,311 | 204,253 | 176,360 | 156,375 |
Change in Working Capital | -62,644 | -147,747 | -51,702 | 73,980 | -10,683 | 15,663 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.